What happened to allergy positions?







"I scratch my head with some of the choices that were made".

I don't know how to tell you this, but you haven't seen anything yet.
The dysfunction and embarrassing decision-making made prior to launch is nothing more than the pre-game layup line; just wait until the product hits the market and it starts taking water.
Well, thank you Mr. Positive!....it’s quite obvious you didn’t get that 2nd and 3rd interview. But who knew you can also see the future, probably should have brought that up during your resume review, might’ve helped!....lol.
 










































Well, thank you Mr. Positive!....it’s quite obvious you didn’t get that 2nd and 3rd interview. But who knew you can also see the future, probably should have brought that up during your resume review, might’ve helped!....lol.
Didn't apply. Why?
If you've seen it once, you certainly do not need to see it a second time.
I am glad you find purpose selling Zyrtec, buy you're still in for one hell of a surprise once launch gets here.
Maybe they can start with the free trial offers in the first six months this time.
 












Didn't apply. Why?
If you've seen it once, you certainly do not need to see it a second time.
I am glad you find purpose selling Zyrtec, buy you're still in for one hell of a surprise once launch gets here.
Maybe they can start with the free trial offers in the first six months this time.
Good point, Remibrutinib has one big advantage, rebound effect leads to addiction
 
























Didn't apply. Why?
If you've seen it once, you certainly do not need to see it a second time.
I am glad you find purpose selling Zyrtec, buy you're still in for one hell of a surprise once launch gets here.
Maybe they can start with the free trial offers in the first six months this time.
Zyrtec?...really?...that’s darling. The hope is to be on the ground floor of a new division and molecule with multiple indications, not just CSU, and billions in revenue in the next 10+ years. But again, you didn’t post, or challenge yourself, so why would we expect you to be excited about anything regarding Remi.
 






























Zyrtec?...really?...that’s darling. The hope is to be on the ground floor of a new division and molecule with multiple indications, not just CSU, and billions in revenue in the next 10+ years. But again, you didn’t post, or challenge yourself, so why would we expect you to be excited about anything regarding Remi.
So, a house-brand Dupixent? Go for it, slugger.
My favorite part of your kool-aid consuming simplicity is "the hope is to be on the ground floor . . ."
Here. At Novartis.
These ignorant fuckers couldn't even launch a product they spent $9B on. Their hired directors that didn't even have B&B experience and thought that giving it away would fix everything.
I wish the best for everyone selling it, including you. Watching the death-march in C.R.M. sucks, and I don't wish it on anyone.
That said, if you have been here for a while, you know what is coming & no amount of self-delusion will change things.